Biotin Injection vs Palmitoyl Tetrapeptide-7
A side-by-side research comparison of Biotin Injection and Palmitoyl Tetrapeptide-7 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Biotin Injection | Palmitoyl Tetrapeptide-7 |
|---|---|---|
| Full name | Biotin (Vitamin B7) Injectable | Palmitoyl Tetrapeptide-7 (Pal-GQPR) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Compounded supplement | Research compound |
| Mechanism | Essential cofactor for carboxylase enzymes involved in keratin production, fatty acid synthesis, and amino acid metabolism critical for hair follicle health and nail matrix function. | Inhibits IL-6 release from keratinocytes and reduces inflammation-mediated MMP activation, preserving existing collagen while complementing Pal-GHK collagen building. |
| Molecular weight | 244.31 Da | 693 Da |
| Half-life | ~2 hours | 8-12 hours (topical) |
| Bioavailability | ~100% injectable | Good (topical) |
| Typical dose | 1-10 mg IM | 2-4% in formulation |
| Frequency | 1-2x per week | 1-2x daily |
| Route | Intramuscular injection | Topical |
Biotin Injection reported benefits
- Hair growth support
- Nail strengthening
- Skin health
- Keratin production
- Metabolic support
Palmitoyl Tetrapeptide-7 reported benefits
- Anti-inflammatory (skin)
- Reduces IL-6
- Prevents collagen degradation
- Combats inflammaging
Related comparisons
Research and educational reference only. Not medical advice.